These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36330479)

  • 1. Oncological outcomes of neoadjuvant chemotherapy in patients with resectable synchronous colorectal liver metastasis: A result from a propensity score matching study.
    Jiang YJ; Zhou SC; Chen JH; Liang JW
    Front Oncol; 2022; 12():951540. PubMed ID: 36330479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores-- A retrospective, propensity score matching analysis.
    Chen FL; Wang YY; Liu W; Xing BC
    Front Oncol; 2022; 12():973418. PubMed ID: 36132151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study.
    Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
    J Gastrointest Surg; 2022 Apr; 26(4):772-781. PubMed ID: 34664190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases.
    Ninomiya M; Emi Y; Motomura T; Tomino T; Iguchi T; Kayashima H; Harada N; Uchiyama H; Nishizaki T; Higashi H; Kuwano H
    Int J Clin Oncol; 2021 Dec; 26(12):2255-2264. PubMed ID: 34519930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy versus upfront surgery as the initial treatment for patients with resectable, synchronous colorectal cancer liver metastases.
    Lee JM; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Min BS
    J Surg Oncol; 2023 Sep; 128(4):549-559. PubMed ID: 37288777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
    Chen Y; Xu Y; Xu L; Han F; Huang Y; Jiang H; Wu J; Zhang Y
    Front Oncol; 2021; 11():758552. PubMed ID: 34745996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of neoadjuvant chemotherapy in patients with synchronous colorectal liver metastasis: A propensity score matching comparative study.
    Ueno M; Komeda K; Kosaka H; Nakai T; Nomi T; Iida H; Tanaka S; Ikoma H; Matsuda K; Hirokawa F; Matsumoto M; Hokuto D; Mori H; Morimura R; Kaibori M; Yamaue H; Kubo S
    Int J Surg; 2021 Oct; 94():106106. PubMed ID: 34536602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes of Neoadjuvant Chemotherapy in Colorectal Cancer Patients With Synchronous Resectable Liver Metastasis: A Propensity Score Matching Analysis.
    Park SH; Shin JK; Lee WY; Yun SH; Cho YB; Huh JW; Park YA; Heo JS; Choi GS; Kim ST; Park YS; Kim HC
    Ann Coloproctol; 2021 Aug; 37(4):244-252. PubMed ID: 34182620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation May Be a New Treatment Modality for Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
    Chen Y; Huang Y; Xu L; Wu J; Han F; Jiang H; Zheng P; Xu D; Zhang Y
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of surgery in patients with synchronous colorectal cancer liver metastases undergoing neoadjuvant chemotherapy: a propensity score analysis.
    Wang Y; Wen N; Xiong X; Lu J; Li B; Cheng N
    World J Surg Oncol; 2023 Sep; 21(1):276. PubMed ID: 37658360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective Definition and Optimized Strategy for "Biologically Borderline Resectable" Colorectal Liver Metastases.
    Takamoto T; Nara S; Ban D; Mizui T; Murase Y; Esaki M; Shimada K; Hashimoto T; Makuuchi M
    World J Surg; 2023 Nov; 47(11):2834-2845. PubMed ID: 37540268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer?
    Hirokawa F; Asakuma M; Komeda K; Shimizu T; Inoue Y; Kagota S; Tomioka A; Uchiyama K
    Surg Today; 2019 Jan; 49(1):82-89. PubMed ID: 30255329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
    Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
    [No Abstract]   [Full Text] [Related]  

  • 15. Thermal ablation versus hepatic resection for colorectal cancer with synchronous liver metastases: a propensity score matching study.
    Xu Y; Zhang Y; Zheng CZ; Li C; Guo T; Xu Y
    Eur Radiol; 2022 Oct; 32(10):6678-6690. PubMed ID: 35999370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score.
    Yonekawa Y; Uehara K; Mizuno T; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
    Int J Clin Oncol; 2021 Jan; 26(1):126-134. PubMed ID: 33074351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study.
    Chen Q; Zhang R; Xing B; Li C; Xiu D; Chen J; Deng Y; Chen X; Guo R; Chen F; Peng J; Sun T; Wang H; Li M; Zheng Q; Bi X; Zhao J; Zhou J; Li Z; Huang Z; Zhang Y; Zhang Y; Cai J; Zhao H
    Int J Surg; 2022 Oct; 106():106952. PubMed ID: 36220519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy for patients with resectable colorectal cancer liver metastases: A systematic review and meta-analysis.
    Zhang Y; Ge L; Weng J; Tuo WY; Liu B; Ma SX; Yang KH; Cai H
    World J Clin Cases; 2021 Aug; 9(22):6357-6379. PubMed ID: 34435001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes of Perioperative Versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases: An International Multicentre Propensity-Score Matched Analysis with Stratification by Contemporary Risk-Scoring.
    Di Martino M; Primavesi F; Syn N; Dorcaratto D; de la Hoz Rodríguez Á; Dupré A; Piardi T; Rhaiem R; Blanco Fernández G; de Armas Conde N; Rodríguez Sanjuán JC; Fernández Santiago R; Fernández-Moreno MC; Ferret G; López Ben S; Suárez Muñoz MÁ; Perez-Alonso AJ; Koh YX; Jones R; Martín-Pérez E
    Ann Surg Oncol; 2022 Oct; 29(11):6829-6842. PubMed ID: 35849284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Postoperative Infectious Complications on Long-Term Outcomes for Patients Undergoing Simultaneous Resection for Colorectal Cancer Liver Metastases: A Propensity Score Matching Analysis.
    Chen Q; Deng Y; Chen J; Zhao J; Bi X; Zhou J; Li Z; Huang Z; Zhang Y; Chen X; Zhao H; Cai J
    Front Oncol; 2021; 11():793653. PubMed ID: 35071001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.